431 related articles for article (PubMed ID: 23839187)
1. Vitiligo surgical, laser, and alternative therapies: a review and case series.
Wassef C; Lombardi A; Khokher S; Rao BK
J Drugs Dermatol; 2013 Jun; 12(6):685-91. PubMed ID: 23839187
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
3. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
[TBL] [Abstract][Full Text] [Related]
4. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
Mulekar SV; Al Issa A; Al Eisa A
Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
[TBL] [Abstract][Full Text] [Related]
6. Melanocytes transplantation in patients with vitiligo using needling micrografting technique.
Sharquie KE; Noaimi AA; Al-Mudaris HA
J Drugs Dermatol; 2013 May; 12(5):e74-8. PubMed ID: 23652963
[TBL] [Abstract][Full Text] [Related]
7. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
[TBL] [Abstract][Full Text] [Related]
8. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo.
Yu HS; Wu CS; Yu CL; Kao YH; Chiou MH
J Invest Dermatol; 2003 Jan; 120(1):56-64. PubMed ID: 12535198
[TBL] [Abstract][Full Text] [Related]
9. Dermatosurgical techniques for repigmentation of vitiligo.
Rusfianti M; Wirohadidjodjo YW
Int J Dermatol; 2006 Apr; 45(4):411-7. PubMed ID: 16650168
[TBL] [Abstract][Full Text] [Related]
10. Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study.
Budania A; Parsad D; Kanwar AJ; Dogra S
Br J Dermatol; 2012 Dec; 167(6):1295-301. PubMed ID: 22897617
[TBL] [Abstract][Full Text] [Related]
11. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
[TBL] [Abstract][Full Text] [Related]
12. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
[TBL] [Abstract][Full Text] [Related]
13. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
Issa CM; Rehder J; Taube MB
Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
[TBL] [Abstract][Full Text] [Related]
14. The additive effect of excimer laser on non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
Ebadi A; Rad MM; Nazari S; Fesharaki RJ; Ghalamkarpour F; Younespour S
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):745-51. PubMed ID: 25352095
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
Vakharia PP; Lee DE; Khachemoune A
Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
[TBL] [Abstract][Full Text] [Related]
16. Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction?
Sahni K; Parsad D; Kanwar AJ; Mehta SD
Dermatol Surg; 2011 Feb; 37(2):176-82. PubMed ID: 21269348
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
[TBL] [Abstract][Full Text] [Related]
18. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study.
van Geel N; Ongenae K; De Mil M; Naeyaert JM
Dermatol Surg; 2001 Oct; 27(10):873-6. PubMed ID: 11722524
[TBL] [Abstract][Full Text] [Related]
19. Subjective and objective evaluation of noncultured epidermal cellular grafting for repigmenting vitiligo.
van Geel N; Ongenae K; Vander Haeghen Y; Vervaet C; Naeyaert JM
Dermatology; 2006; 213(1):23-9. PubMed ID: 16778422
[TBL] [Abstract][Full Text] [Related]
20. Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study.
Mulekar SV; Ghwish B; Al Issa A; Al Eisa A
Br J Dermatol; 2008 Jan; 158(1):45-9. PubMed ID: 17927795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
